BRD7929   Click here for help

GtoPdb Ligand ID: 11723

PDB Ligand Antimalarial Ligand
Compound class: Synthetic organic
Comment: BRD7929 is an advanced analogue from a bicyclic azetidine series of antimalarial compounds [1].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 48.05
Molecular weight 522.3
XLogP 5.39
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES COc1ccc(cc1)NC(=O)N1CCCCN2[C@@H](C1)[C@H]([C@H]2CN(C)C)c1ccc(cc1)C#Cc1ccccc1
Isomeric SMILES COc1ccc(cc1)NC(=O)N1CCCCN2[C@@H](C1)[C@H]([C@H]2CN(C)C)c1ccc(cc1)C#Cc1ccccc1
InChI InChI=1S/C33H38N4O2/c1-35(2)23-30-32(27-15-13-26(14-16-27)12-11-25-9-5-4-6-10-25)31-24-36(21-7-8-22-37(30)31)33(38)34-28-17-19-29(39-3)20-18-28/h4-6,9-10,13-20,30-32H,7-8,21-24H2,1-3H3,(H,34,38)/t30-,31+,32+/m1/s1
Guide to Malaria Pharmacology Comments
BRD7929 was synthesized during optimization of BRD3444, the hit compound identified from a phenotypic screen of a Diversity-orientated synthesis library [1].

Potential Target/Mechanism Of Action: Correlation of purified cFRS IC50 values against parasite growth inhibition assays for a range of analogues, together with genetic evidence, indicate that PfcFRS is the relevant molecular target of this bicyclic azetidine series [1].